483 Woodfield Pharmaceutical Apr 2017

483 Woodfield Pharmaceutical Apr 2017

Shatina Alridge FDA, Stephen Brown FDA$119.00 - Available Now

FDA investigators audited the Woodfield Pharmaceutical - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 26 Apr 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Apr 2017
  • Location: Houston, United States
  • FEI: 1628196
Add To Cart